Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Res. 2008 Nov 15;68(22):9107-11. doi: 10.1158/0008-5472.CAN-08-2556.

Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer?

Author information

  • 1Department of Cancer Biology, the Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tenessee 37232, USA. li.yang@vanderbilt.edu

Abstract

Therapies targeting transforming growth factor beta (TGFbeta) signaling using neutralizing antibodies and small molecular inhibitors are in multiple clinical trails. However, TGFbeta is known to work as both a tumor suppressor and a tumor promoter, and current knowledge does not provide sufficient information on what factors mediate this switch in function and when this switch occurs. Recent advances in multiple disciplines suggest that immune cells from the tumor host may provide the answer.

PMID:
19010878
PMCID:
PMC2741321
DOI:
10.1158/0008-5472.CAN-08-2556
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center